Helen Heslop is a professor in the hematology-oncology section of the Departments of Medicine and Pediatrics at Baylor College of Medicine (BCM) in Houston. She is also director of the Center for Cell and Gene Therapy at BCM and Texas Children’s Hospital and leader in cancer cell and gene therapy at Baylor’s Dan L. Duncan Comprehensive Cancer Center.
She is a physician-scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells, to improve hemopoietic stem cell transplantation and cancer therapy. She has an additional focus in reconstituting antiviral immunity post-transplant.
Heslop received her MD from University of Otago, New Zealand, and completed a postdoctoral research fellowship at St. Jude Children’s Research Hospital in Memphis, Tennessee. She was conferred with an honorary doctoral degree in science by the University of Otago.